BillionToOne, Inc. (BLLN) vs Twist Bioscience Corporation (TWST)
BillionToOne, Inc. and Twist Bioscience Corporation are both Diagnostics & Research companies. Twist Bioscience Corporation is the larger, with a market value of $12.4B against $5.9B — 2.1× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; BillionToOne, Inc. trades at 119×. BillionToOne, Inc. has the higher net margin (8.35% vs −31.7%) and the higher return on invested capital (34.1% vs −30.8%). Across the 16 metrics below, BillionToOne, Inc. leads on 15 and Twist Bioscience Corporation on 1.
Valuation
Profitability
| Metric | BLLN | TWST | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.27% | 51.97% | 50.89% |
| Operating margin | 10.90% | (33.58%) | (8.57%) |
| Net margin | 8.35% | (31.66%) | (6.37%) |
| Free cash flow margin | 8.35% | (22.15%) | 0.00% |
| Return on equity | 23.27% | (29.59%) | (2.92%) |
| Return on assets | 9.09% | (20.78%) | (6.71%) |
| Return on invested capital | 34.10% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack